PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (NYSE: CNK), one of the largest motion picture exhibitors in the world, today reported results for the three and nine months ended September 30, 2017.
Cinemark Holdings, Inc.’s total revenues for the three months ended September 30, 2017 was $710.8 million compared to $768.6 million for the three months ended September 30, 2016. For the three months ended September 30, 2017, admissions revenues were $425.1 million and concession revenues were $247.1 million. Concession revenues per patron increased 7.0% to $3.67 and average ticket price increased 1.8% to $6.32 for the three months ended September 30, 2017.
Net income attributable to Cinemark Holdings, Inc. for the three months ended September 30, 2017 was $38.1 million compared to $65.7 million for the three months ended September 30, 2016. Diluted earnings per share for the three months ended September 30, 2017 was $0.33 compared to $0.56 for the three months ended September 30, 2016.
Adjusted EBITDA for the three months ended September 30, 2017 was $153.7 million compared to $184.9 million for the three months ended September 30, 2016. Reconciliations of non-GAAP financial measures are provided in the financial schedules accompanying this press release.
“We continued our trend of outperforming the North American box office in the third quarter, beating industry results by approximately 200 basis points. We have now exceeded market growth for 31 out of 35 quarters,” stated Mark Zoradi, Cinemark’s Chief Executive Officer. “We are pleased to yet again deliver consistent results, despite the weaker consumer appeal of this summer’s film content, and we remain enthusiastic about the long-term prospects of our industry and film line-up for the remainder of 2017 and beyond.”
Cinemark Holdings, Inc.’s total revenues for the nine months ended September 30, 2017 were $2,241.6 million compared to $2,217.9 million for the nine months ended September 30, 2016. During the nine months ended September 30, 2017, admissions revenues were $1,351.5 million and concession revenues were $777.6 million. Concession revenues per patron increased 8.5% to $3.69 and average ticket price increased 4.1% to $6.41 for the nine months ended September 30, 2017.
Net income attributable to Cinemark Holdings, Inc. for the nine months ended September 30, 2017 was $169.1 million compared to $178.1 million for the nine months ended September 30, 2016. Diluted earnings per share for the nine months ended September 30, 2017 was $1.45 compared to $1.53 for the nine months ended September 30, 2016. Net income for the nine months ended September 30, 2016 was impacted by a pre-tax loss on debt amendments and refinancing of $13.3 million, which was primarily due to the refinancing of the Company’s 7.375% senior subordinated notes with an add-on to the Company’s 4.875% senior notes.
Adjusted EBITDA for the nine months ended September 30, 2017 was $536.2 million compared to $537.9 million for the nine months ended September 30, 2016. Reconciliations of non-GAAP financial measures are provided in the financial schedules accompanying this press release.
On September 30, 2017, the Company’s aggregate screen count was 5,957. As of September 30, 2017, the Company had signed commitments to open two new theatres and 16 screens by the end of 2017 and open 17 new theatres with 140 screens subsequent to 2017.
Conference Call/Webcast – Today at 8:30AM ET
Telephone: via 800-374-1346 or 706-679-3149 (for international callers).
Live Webcast/Replay: Available live at investors.cinemark.com. A replay will be available following the call and archived for a limited time.
About Cinemark Holdings, Inc.
Cinemark is a leading domestic and international motion picture exhibitor, operating 533 theatres with 5,957 screens in 41 U.S. states, Brazil, Argentina and 13 other Latin American countries as of September 30, 2017. For more information go to investors.cinemark.com.
Forward-looking Statements
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The “forward-looking statements” include our current expectations, assumptions, estimates and projections about our business and our industry. They include statements relating to future revenues, expenses and profitability, the future development and expected growth of our business, projected capital expenditures, attendance at movies generally or in any of the markets in which we operate, the number or diversity of popular movies released and our ability to successfully license and exhibit popular films, national and international growth in our industry, competition from other exhibitors and alternative forms of entertainment and determinations in lawsuits in which we are defendants. You can identify forward-looking statements by the use of words such as “may,” “should,” “could,” “estimates,” “predicts,” “potential,” “continue,” “anticipates,” “believes,” “plans,” “expects,” “future” and “intends” and similar expressions which are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. In evaluating forward-looking statements, you should carefully consider the risks and uncertainties described in the “Risk Factors” section or other sections in the Company’s Annual Report on Form 10-K filed February 23, 2017 and quarterly reports on Form 10-Q. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements and risk factors. Forward-looking statements contained in this press release reflect our view only as of the date of this press release. We undertake no obligation, other than as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
| Cinemark Holdings, Inc. | ||||||||||||||||||||
| Financial and Operating Summary | ||||||||||||||||||||
| (unaudited, in thousands) | ||||||||||||||||||||
|
Three months ended |
Nine months ended |
|||||||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||||||
| Statement of income data: | ||||||||||||||||||||
| Revenues | ||||||||||||||||||||
| Admissions | $ | 425,128 | $ | 472,842 | $ | 1,351,477 | $ | 1,364,737 | ||||||||||||
| Concession | 247,027 | 261,391 | 777,573 | 752,798 | ||||||||||||||||
| Other | 38,593 | 34,341 | 112,503 | 100,312 | ||||||||||||||||
| Total revenues | 710,748 | 768,574 | 2,241,553 | 2,217,847 | ||||||||||||||||
| Cost of operations | ||||||||||||||||||||
| Film rentals and advertising | 226,229 | 249,766 | 725,603 | 733,101 | ||||||||||||||||
| Concession supplies | 40,178 | 41,888 | 124,117 | 116,999 | ||||||||||||||||
| Facility lease expense | 81,919 | 82,848 | 248,569 | 241,904 | ||||||||||||||||
| Other theatre operating expenses | 179,646 | 179,459 | 533,069 | 509,339 | ||||||||||||||||
| General and administrative expenses | 36,947 | 35,290 | 112,997 | 109,143 | ||||||||||||||||
| Depreciation and amortization | 58,052 | 54,187 | 174,545 | 155,874 | ||||||||||||||||
| Impairment of long-lived assets | 5,026 | 406 | 9,600 | 2,323 | ||||||||||||||||
| Loss on sale of assets and other | 8,576 | 6,940 | 9,464 | 10,985 | ||||||||||||||||
| Total cost of operations | 636,573 | 650,784 | 1,937,964 | 1,879,668 | ||||||||||||||||
| Operating income | 74,175 | 117,790 | 303,589 | 338,179 | ||||||||||||||||
| Interest expense (1) | (26,317 | ) | (26,659 | ) | (79,208 | ) | (81,980 | ) | ||||||||||||
| Loss on debt amendments and refinancing | - | - | (246 | ) | (13,284 | ) | ||||||||||||||
| Distributions from NCM | 2,144 | 1,381 | 11,704 | 10,117 | ||||||||||||||||
| Foreign currency exchange gain | 584 | 485 | 2,018 | 2,883 | ||||||||||||||||
| Other income | 12,584 | 14,055 | 31,162 | 29,627 | ||||||||||||||||
| Income before income taxes | 63,170 | 107,052 | 269,019 | 285,542 | ||||||||||||||||
| Income taxes | 24,630 | 40,926 | 98,475 | 106,002 | ||||||||||||||||
| Net income | $ | 38,540 | $ | 66,126 | $ | 170,544 | $ | 179,540 | ||||||||||||
| Less: Net income attributable to noncontrolling interests | 401 | 471 | 1,438 | 1,454 | ||||||||||||||||
| Net income attributable to Cinemark Holdings, Inc. | $ | 38,139 | $ | 65,655 | $ | 169,106 | $ | 178,086 | ||||||||||||
|
Earnings per share attributable to Cinemark Holdings, Inc.’s common stockholders: |
||||||||||||||||||||
| Basic | $ | 0.33 | $ | 0.56 | $ | 1.45 | $ | 1.53 | ||||||||||||
| Diluted | $ | 0.33 | $ | 0.56 | $ | 1.45 | $ | 1.53 | ||||||||||||
| Weighted average diluted shares outstanding | 116,104 | 115,793 | 116,063 | 115,706 | ||||||||||||||||
| Other financial data: | ||||||||||||||||||||
| Adjusted EBITDA (2) | $ | 153,672 | $ | 184,891 | $ | 536,231 | $ | 537,933 | ||||||||||||
|
________________________________ |
||||
| (1) | Includes amortization of debt issue costs. | |||
| (2) | Adjusted EBITDA is a non-GAAP financial measure. A reconciliation of Adjusted EBITDA to net income, the most comparable GAAP measure, is provided in the financial schedules accompanying this press release. | |||
| As of | As of | |||||||
| September 30, | December 31, | |||||||
| 2017 | 2016 | |||||||
| Balance sheet data: | ||||||||
| Cash and cash equivalents | $ | 469,446 | $ | 561,235 | ||||
| Theatre properties and equipment, net | $ | 1,791,606 | $ | 1,704,536 | ||||
| Total assets | $ | 4,371,650 | $ | 4,306,633 | ||||
| Long-term debt, including current portion | $ | 1,789,051 | $ | 1,788,112 | ||||
| Equity | $ | 1,351,820 | $ | 1,272,960 | ||||
|
Three months ended |
Nine months ended |
|||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||
| Other operating data: | ||||||||||||||||
| Attendance (patrons, in millions): | ||||||||||||||||
| Domestic | 40.6 | 48.0 | 130.1 | 138.0 | ||||||||||||
| International | 26.7 | 28.2 | 80.9 | 83.7 | ||||||||||||
| Worldwide | 67.3 | 76.2 | 211.0 | 221.7 | ||||||||||||
| Average ticket price (in dollars): | ||||||||||||||||
| Domestic | $ | 7.69 | $ | 7.39 | $ | 7.71 | $ | 7.52 | ||||||||
| International | $ | 4.22 | $ | 4.18 | $ | 4.30 | $ | 3.91 | ||||||||
| Worldwide | $ | 6.32 | $ | 6.21 | $ | 6.41 | $ | 6.16 | ||||||||
| Concession revenues per patron (in dollars): | ||||||||||||||||
| Domestic | $ | 4.47 | $ | 4.11 | $ | 4.48 | $ | 4.17 | ||||||||
| International | $ | 2.46 | $ | 2.27 | $ | 2.42 | $ | 2.12 | ||||||||
| Worldwide | $ | 3.67 | $ | 3.43 | $ | 3.69 | $ | 3.40 | ||||||||
| Average screen count (month end average): | ||||||||||||||||
| Domestic | 4,553 | 4,563 | 4,547 | 4,547 | ||||||||||||
| International | 1,386 | 1,317 | 1,367 | 1,299 | ||||||||||||
| Worldwide | 5,939 | 5,880 | 5,914 | 5,846 | ||||||||||||
| Segment Information | ||||||||||||||||||||
|
(unaudited, in thousands) |
||||||||||||||||||||
|
Three months ended |
Nine months ended |
|||||||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||||||
| Revenues | ||||||||||||||||||||
| U.S. | $ | 514,376 | $ | 572,916 | $ | 1,650,514 | $ | 1,677,365 | ||||||||||||
| International | 200,122 | 199,476 | 602,116 | 551,212 | ||||||||||||||||
| Eliminations | (3,750 | ) | (3,818 | ) | (11,077 | ) | (10,730 | ) | ||||||||||||
| Total revenues | $ | 710,748 | $ | 768,574 | $ | 2,241,553 | $ | 2,217,847 | ||||||||||||
| Adjusted EBITDA | ||||||||||||||||||||
| U.S. | $ | 108,854 | $ | 137,540 | $ | 402,902 | $ | 409,018 | ||||||||||||
| International | 44,818 | 47,351 | 133,329 | 128,915 | ||||||||||||||||
| Total Adjusted EBITDA | $ | 153,672 | $ | 184,891 | $ | 536,231 | $ | 537,933 | ||||||||||||
| Capital expenditures | ||||||||||||||||||||
| U.S. | $ | 65,612 | $ | 75,839 | $ | 221,604 | $ | 175,218 | ||||||||||||
| International | 14,318 | 22,984 | 41,126 | 55,128 | ||||||||||||||||
| Total capital expenditures | $ | 79,930 | $ | 98,823 | $ | 262,730 | $ | 230,346 | ||||||||||||
| Reconciliation of Adjusted EBITDA | ||||||||||||||||||||
| (unaudited, in thousands) | ||||||||||||||||||||
| Three months ended | Nine months ended | |||||||||||||||||||
| September 30, | September 30, | |||||||||||||||||||
| 2017 | 2016 | 2017 | 2016 | |||||||||||||||||
| Net income | $ | 38,540 | $ | 66,126 | $ | 170,544 | $ | 179,540 | ||||||||||||
| Income taxes | 24,630 | 40,926 | 98,475 | 106,002 | ||||||||||||||||
| Interest expense | 26,317 | 26,659 | 79,208 | 81,980 | ||||||||||||||||
| Other income | (13,168 | ) | (14,540 | ) | (33,180 | ) | (32,510 | ) | ||||||||||||
| Loss on debt amendments and refinancing | - | - | 246 | 13,284 | ||||||||||||||||
| Other cash distributions from equity investees (2) | 2,402 | 1,391 | 17,321 | 9,660 | ||||||||||||||||
| Depreciation and amortization | 58,052 | 54,187 | 174,545 | 155,874 | ||||||||||||||||
| Impairment of long-lived assets | 5,026 | 406 | 9,600 | 2,323 | ||||||||||||||||
| Loss on sale of assets and other | 8,576 | 6,940 | 9,464 | 10,985 | ||||||||||||||||
| Deferred lease expenses - theatres (3) | (44 | ) | 70 | (278 | ) | (111 | ) | |||||||||||||
| Deferred lease expenses – DCIP equipment (4) | (253 | ) | (232 | ) | (741 | ) | (698 | ) | ||||||||||||
| Amortization of long-term prepaid rents (3) | 551 | 371 | 1,540 | 1,357 | ||||||||||||||||
| Share based awards compensation expense (5) | 3,043 | 2,587 | 9,487 | 10,247 | ||||||||||||||||
| Adjusted EBITDA (1) | $ | 153,672 | $ | 184,891 | $ | 536,231 | $ | 537,933 | ||||||||||||
| (1) | Adjusted EBITDA as calculated in the chart above represents net income before income taxes, interest expense, other income, loss on debt amendments and refinancing, other cash distributions from equity investees, depreciation and amortization, impairment of long-lived assets, loss on sale of assets and other, changes in deferred lease expense, amortization of long-term prepaid rents and share based awards compensation expense. Adjusted EBITDA is a non-GAAP financial measure commonly used in our industry and should not be construed as an alternative to net income as an indicator of operating performance or as an alternative to cash flow provided by operating activities as a measure of liquidity (as determined in accordance with GAAP). Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. We have included Adjusted EBITDA because we believe it provides management and investors with additional information to measure our performance and liquidity, estimate our value and evaluate our ability to service debt. In addition, we use Adjusted EBITDA for incentive compensation purposes. Adjusted EBITDA margin represents Adjusted EBITDA divided by total revenues. | |
| (2) | Represents cash distributions received from equity investees that were recorded as a reduction of the respective investment balances. | |
| (3) | Non-cash expense included in facility lease expense. | |
| (4) | Non-cash expense included in other theatre operating expenses. | |
| (5) | Non-cash expense included in general and administrative expenses. |
